Astera Labs vs. AppLovin: Which Technology Stock Is a Better Buy in 2026?

The article contrasts AI infrastructure hardware maker Astera Labs with ad-tech software platform AppLovin, arguing for Astera as the better 2026 risk-to-reward despite a narrow data point on AppLovin’s quarter. Astera reported FY2025 revenue of $852.5M (+115.1% YoY) with net income of ~$219.1M and strong liquidity (current ratio 10.2x) versus AppLovin’s FY2025 revenue near $5.5B (+70.0%) and net income ~$3.3B. Key risks highlighted include Astera’s customer concentration (one end customer >70% of revenue) and AppLovin’s regulatory overhang (Dutch class action on tracking; U.S. securities fraud complaints) plus a stated revenue/forward-guidance miss that drove a sharp post-earnings drop.

Analysis

The market is likely still mispricing these as the same “AI winners,” when they have very different failure modes. ALAB is a capex derivative on a handful of hyperscale buildouts: excellent upside if the build cycle keeps stretching, but very little forgiveness if one customer pauses qualification or inventory normalizes. APP is the opposite—less pristine optics, but a cash machine whose downside is more about policy, legal, and platform-friction shocks than demand disappearing overnight.

Second-order, the more crowded trade is probably ALAB: interconnect and rack-scale infrastructure names tend to trade on forward ordering expectations, so any hint of slower AI server deployment can compress multiples before fundamentals roll over. APP’s risk is more binary and slower-moving; changes in Apple/Google/Meta auction mechanics or privacy enforcement can quietly erode monetization, but the business has enough free cash flow to cushion headline risk and repurchase stock if sentiment stabilizes.

Contrarian read: consensus is treating “AI infrastructure” as structurally safer than “adtech,” but the valuation spread implies ALAB needs near-flawless execution while APP is already priced for disappointment. On a 6-18 month basis, I’d rather own the business with visible capital return and a discounted entry point than the one whose valuation assumes uninterrupted hyperscaler spend. What would falsify that view is a fresh hyperscaler capex acceleration or a clean APP quarter with improving growth and no material legal escalation.

Key Decisions for Investors

• Prefer a relative-value expression: long APP / short ALAB for 3-6 months, looking for 15-20% spread compression if APP stabilizes and ALAB’s multiple de-rates on any AI capex disappointment. Stop if ALAB delivers a second straight quarter of upside guide revisions or if APP’s legal/regulatory headlines worsen materially.
• Do not chase ALAB into strength; wait for a post-earnings pullback or a weaker hyperscaler capex signal before initiating longs. The stock is a momentum beneficiary, but at this valuation a single customer comment can unwind several turns of multiple quickly.
• If you want upside convexity in APP, use 3-6 month call spreads rather than outright equity only after the next print confirms revenue stabilization. This keeps exposure to a rerating while limiting damage if platform-policy or litigation noise resurfaces.
• Use NVDA/AMZN/MSFT/GOOGL capex commentary as the key trigger for ALAB exposure. A downgrade in hyperscaler spending plans would be the cleanest signal to short ALAB or trim any AI hardware basket exposure.
• Watch for APP buyback support or margin durability as the confirmation signal; if free cash flow remains strong despite slower top-line growth, the market may be underappreciating the stock’s ability to self-fund a rerating.